NLRP3 agonist enhances radiation-induced immune priming and promotes abscopal responses in anti-PD1 resistant model

por Barsoumian, Hampartsoum B., He, Kewen, Hsu, Ethan, Bertolet, Genevieve, Sezen, Duygu, Hu, Yun, Cortez, Maria Angelica, Welsh, James W.
Publicado 2023

NLRP3 agonist enhances radiation-induced immune priming and promotes abscopal responses in anti-PD1 resistant model

por Barsoumian, Hampartsoum B., He, Kewen, Hsu, Ethan, Bertolet, Genevieve, Sezen, Duygu, Hu, Yun, Riad, Thomas S., Cortez, Maria Angelica, Welsh, James W.
Publicado 2023

Durable control of metastases in an HLA-A2+ patient with refractory melanoma after low-dose radiotherapy in combination with MAGE-A4 T cell therapy: a case report

por He, Kewen, Hong, David S., Ke, Danxia, Kebriaei, Partow, Wang, Tianjiao, Danesi, Hassan, Bertolet, Genevieve, Leuschner, Carola, Puebla-Osorio, Nahum, Voss, Tiffany A., Lin, Quan, Norry, Elliot, Fracasso, Paula M., Welsh, James W.
Publicado 2023

Novel Use of Low-Dose Radiotherapy to Modulate the Tumor Microenvironment of Liver Metastases

por He, Kewen, Barsoumian, Hampartsoum B., Bertolet, Genevieve, Verma, Vivek, Leuschner, Carola, Koay, Eugene J., Ludmir, Ethan B., Hsu, Ethan, Pisipati, Esha, Voss, Tiffany A., Puebla-Osorio, Nahum, Cortez, Maria Angelica, Welsh, James W.
Publicado 2021

Combining a nanoparticle-mediated immunoradiotherapy with dual blockade of LAG3 and TIGIT improves the treatment efficacy in anti-PD1 resistant lung cancer

por Hu, Yun, Paris, Sébastien, Bertolet, Genevieve, Barsoumian, Hampartsoum B., He, Kewen, Sezen, Duygu, Chen, Dawei, Wasley, Mark, SILVA, Jordan DA, Mitchell, Joylise A., Voss, Tiffany A., Masrorpour, Fatemeh, Leyton, Claudia Kettlun, Yang, Liangpeng, Leuschner, Carola, Puebla-Osorio, Nahum, Gandhi, Saumil, Nguyen, Quynh-Nhu, Cortez, Maria Angelica, Welsh, James W.
Publicado 2022

NBTXR3 improves the efficacy of immunoradiotherapy combining nonfucosylated anti-CTLA4 in an anti-PD1 resistant lung cancer model

por Hu, Yun, Paris, Sébastien, Bertolet, Genevieve, Barsoumian, Hampartsoum B., Wang, Qi, Da Silva, Jordan, Patel, Nalini B., Nguyen, Nguyen, Doss, Denaha J., Huang, Ailing, Hsu, Ethan, Leyton, Claudia S. Kettlun, Voss, Tiffany A., Masrorpour, Fatemeh, Leuschner, Carola, Pietz, Jordan T., Puebla-Osorio, Nahum, Gandhi, Saumil, Nguyen, Quynh-Nhu, Wang, Jing, Cortez, Maria Angelica, Welsh, James W.
Publicado 2022

Nanoparticle-enhanced proton beam immunoradiotherapy drives immune activation and durable tumor rejection

por Hu, Yun, Paris, Sébastien, Sahoo, Narayan, Bertolet, Genevieve, Wang, Qi, Wang, Qianxia, Barsoumian, Hampartsoum B., Da Silva, Jordan, Huang, Ailing, Doss, Denaha J., Pollock, David P., Hsu, Ethan, Selene, Nanez, Leyton, Claudia S. Kettlun, Voss, Tiffany A., Masrorpour, Fatemeh, Ganjoo, Shonik, Leuschner, Carola, Pietz, Jordan T., Puebla-Osorio, Nahum, Gandhi, Saumil, Nguyen, Quynh-Nhu, Wang, Jing, Cortez, Maria Angelica, Welsh, James W.
Publicado 2023